What is Emergent Biosolutions's FX effect on cash?

Emergent Biosolutions (EBS) reported FX effect on cash of $0 in Q1 2026.

How has Emergent Biosolutions's FX effect on cash changed year-over-year?

Emergent Biosolutions's FX effect on cash increased by 100.0% year-over-year, from -$700K to $0.

What is the long-term trend for Emergent Biosolutions's FX effect on cash?

Over 2 years (2022 to 2024), Emergent Biosolutions's FX effect on cash has grown at a -100.0% compound annual growth rate (CAGR), from $500K to $0.

What does FX effect on cash mean?

The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.

Emergent Biosolutions EBS FX Effect on Cash

FX Effect on Cash at other companies

Thermo Fisher ScientificTMO

$78M+111%

Regeneron PharmaceuticalsREGN

-$900K-250%

AMP

Amphastar PharmaceuticalsAMPH

-$138K-217%

Amneal Pharmaceuticals, Inc.AMRX

-$1.02M-118%

CorMedixCRMD

$0—

Opko HealthOPK

-$908K-143%

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's FX effect on cash?: Emergent Biosolutions (EBS) reported FX effect on cash of $0 in Q1 2026.
How has Emergent Biosolutions's FX effect on cash changed year-over-year?: Emergent Biosolutions's FX effect on cash increased by 100.0% year-over-year, from -$700K to $0.
What is the long-term trend for Emergent Biosolutions's FX effect on cash?: Over 2 years (2022 to 2024), Emergent Biosolutions's FX effect on cash has grown at a -100.0% compound annual growth rate (CAGR), from $500K to $0.
What does FX effect on cash mean?: The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.